NF-kB p65 Antibody - #AF5006

NF-kB p65 Antibody - FIGURE 2|Byakangelicin alleviates liver injury in a carbon tetrachloride-induced model.

NF-kB p65 Antibody - Figure 6.

NF-kB p65 Antibody - Figure 6 Western blot analysis revealed that the silencing of MyD88 markedly inhibited the expression NF-κB (p65), p-NF-κB (p-p65), AP-1 (c-jun) and p-AP-1 (p-c-jun) protein in the SW480 and HCT116 cells.

NF-kB p65 Antibody - Figure 3.

NF-kB p65 Antibody - FIG.

NF-kB p65 Antibody - Figure 1.

NF-kB p65 Antibody - FIGURE 7 NF-κB/TWIST1 mediates the effect of S.

NF-kB p65 Antibody - Figure 6.

NF-kB p65 Antibody - FIGURE 4 The deficiency of Smad4 inhibited the inflammatory response in a cellular model of human insulin resistance.

NF-kB p65 Antibody - Figure 3.

NF-kB p65 Antibody - Figure 3 THP-1-derived macrophages regulate Ang1 and NF-κB pathways in HUVECs.

NF-kB p65 Antibody - Figure 10.

NF-kB p65 Antibody - FIGURE 8 Effects of OCOP and COP on the NF-κB pathway in DSS-induced mice (A) Representative Western blotting images of pIκBα, IκBα, cytoplasmic p65 and nuclear p65 (B–E) The protein expression levels of pIκBα, IκBα, cytoplasmic p65 and nuclear p65 in the NF-κB pathway.

NF-kB p65 Antibody - Figure 3 Treatment with HP promotes apoptosis of Dami cells through the NF-κB/IL-17 pathway.

NF-kB p65 Antibody - FIGURE 6 The protein levels of Dectin1, TLR2, TLR4, and their associated downstream effector NF-κBp65 are declined post sodium houttuyfonate (SH) management.

NF-kB p65 Antibody - Figure 3 Nampt promoted LPS-induced inflammation in MC3T3-E1 cells.

NF-kB p65 Antibody - Figure 5 Tumor necrosis factor-induced protein-8 (TIPE)-mediated activation of the PI3K/Akt pathway is involved in the modulation of DcR3 levels in HCT116 cells.

NF-kB p65 Antibody - Figure 8 Inhibition of TLR4/MAPK/NF-κB signaling pathway.

NF-kB p65 Antibody - Figure 6: |MEL attenuated the protein levels of NLRP3, TLR4, NF-κB, and caspase-1 of the terminal ileum tissues in NEC mice.

NF-kB p65 Antibody - FIGURE 5 Effects of POL, ACT, and FTB on Keap1-Nrf2 and NF-κB p65 signaling pathways in TNF-α-induced cell injury in A549 cells (A,B) Western blot analyses of nucl-Nrf2, cyto-Nrf2, Keap1, nucl-p65, cyto-p65, and p-IκBα (C–F) Intensity of Keap1, cyto-Nrf2, p-IκBα, and cyto-p65 relative to β-actin.

NF-kB p65 Antibody - Figure 5 Effect of TOLLIP knockdown and overexpression on the PQ-induced activation of NLRP3 inflammasome in HK-2 cells.

NF-kB p65 Antibody - FIGURE 3 Effect of DPSC‐Exos on the expression of TLR4, MyD88, NF‐κB p65 and HMGB1 on day 7 after cerebral I/R damage.

NF-kB p65 Antibody - Figure 6 BE-BJO inhibited the activation of the NF-κB signaling pathway.

NF-kB p65 Antibody - FIGURE 9 Effects of SAL on the NF-κB signaling pathway.

NF-kB p65 Antibody - Figure 6 |C-PC treatment suppresses the expression of NLRP3 inflammasome and NF-κB signaling pathway in lung tissues.

NF-kB p65 Antibody - FIGURE 2 | Effects of the RvE1 and LXA4 combination on NF-κB modification.

NF-kB p65 Antibody - FIGURE 2 Nicotine aggravates inflammation, oxidative stress and endoplasmic reticulum stress of cochlear hair cells.

NF-kB p65 Antibody - Figure 4 miR-155-5p activates the NF-κB signaling pathway in IFN-γ-treated SGECs.

NF-kB p65 Antibody - Figure 4 Effects of Y-1 and Y-2 on NRK-52e cells’ inflammatory cytokines stimulated by sodium oleate with/without CD36 silences representative.

NF-kB p65 Antibody - FIGURE 4| The deficiency of Smad4 inhibited the inflammatory response in a cellular model of human insulin resistance.

NF-kB p65 Antibody - FIGURE 9 Effects of PAR-1 knockdown on p-NF-κB p65 by western blot (a) as well as NF-κB p65 (b) and p-NF-κB p65 (c) by immunofluorescence in SH-SY5Y cells treated with high glucose.

NF-kB p65 Antibody - Figure 10 RBFOX1 affects the NF-κB and NRF2/HO-1 pathway in H/R-induced HK-2 cells.

NF-kB p65 Antibody - Figure 4 Effect of MG activated CAP-SIRT1 pathway on NF-κB-mediated inflammatory response in rat macrophages.

NF-kB p65 Antibody - FIGURE 5 | Feline and human BCA2 restrict HIV-1 transcription by preventing HIV-1-induced activation of NF-κB.

$FIGURE 5 | Feline and human BCA2 restrict HIV-1 transcription by preventing HIV-1-induced activation of NF-κB. (A) HEK293T cells were co-transfected with 250 ng different variants of BCA2 along with 250 ng of pNF-κB-Luc reporter plasmid and 1 µg of pNL43. After 48 h, the cells were lysed and analyzed for luciferase activity and by western blotting with anti-Flag, and anti-tubulin antibodies. (B,C) Five million HEK293T cells were transfected with 5 µg of VR1012, hBCA2, fBCA2, hBCA2 CA, or fBCA2 CA. After 48 h, cytoplasmic and nuclear fractions were separated and analyzed by western blotting to evaluate NF-κB 1(p105/p50), NF-κB p65, BCA2, GAPDH, and Histone H3 in each fraction. Results of quantitative band scan analysis of NF-κB p50/p65 were shown below, and the percentage of VR1012 quantifications are set to 100%. (D) HEK293T cells were co-transfected with 1 µg of pNL43, 500 ng of hBCA2-Flag, fBCA2-Flag, or VR1012, and the levels of nef RNA were analyzed at 10, 22, and 28 h by RT-qPCR after transfection, and the cell lysates were analyzed by western blotting with anti-Flag, and anti-tubulin antibodies. (E) HEK293T cells were co-transfected with 1 µg of pNL43, 500 ng of different variants of BCA2 or VR1012, and the levels of nef RNA were analyzed 48 h later by RT-qPCR, and the cell lysates were analyzed by western blotting with anti-Flag, and anti-tubulin antibodies. The data were presented as the means ± SDs for three independent experiments. Statistical significance was analyzed by using Student’s t-test. Significant differences are indicated as follows: *P < 0.05; **P < 0.01.$

NF-kB p65 Antibody - Figure 7 Effects of BJXZ pills on liver p65, P-p65, Nrf2, and HO-1 expression in rats with hepatic fibrosis.

NF-kB p65 Antibody - FIGURE 7 Spinal cord nuclear factor‐kappa B (NF‐κB) translocation from the cytoplasm to the nucleus induced by bone cancer pain (BCP).

NF-kB p65 Antibody - Figure 5 WKYMVm inhibited the ERK1/2 and NF-κB p65 signaling pathways and affected the p38 signaling pathway in microglial cells.

NF-kB p65 Antibody - Figure 6 NF-κB nuclear transfer decreased in the mouse kidney.

NF-kB p65 Antibody - FIGURE 6 Transplantation of FG‐4592 preconditioned bone marrow stromal cell (BMSCs) inhibits microglial activation and inflammation.

NF-kB p65 Antibody - FIGURE 4 Cytoplasmic mtDNA markedly activated STING signalling.

NF-kB p65 Antibody - Figure 4 Immunohistochemical staining of TLR4 (a), NF-κB (b), Bax (c), and Bcl-2 (d) and semiquantitative analysis of these proteins expression (e) in intestinal tissues of mice.

NF-kB p65 Antibody - FIGURE 7 Nesfatin‐1 prevented activation of NF‐κB signaling in SCI mice.

NF-kB p65 Antibody - Figure 9 Nrf2 overexpression in vitro promotes PPARγ but inhibits NF-κB nuclear translocation; n = 3 experiments per group.

NF-kB p65 Antibody - Figure 5 The expression degrees of HMGB1, TLR4, NF-κB, p-38 MAPK, and ERK1/2 proteins (x¯ ±s).

NF-kB p65 Antibody - Figure 7 The effect of OBB on the TLR4/NF-κB signaling pathway in 5-FU-induced IM mice.

NF-kB p65 Antibody - Figure 7 XFZYD inhibited the IKBα/NF-κB signaling in rat models with CPB-induced ALI.

NF-kB p65 Antibody - Figure 6 BA changed the levels of NF-κB, TLR2, and MYD88 in the lung tissue of COPD rats by immunohistochemical staining and semiquantitative analysis (×100).

NF-kB p65 Antibody - Figure 7 BA improved the expressions of MYD88, p–NF–κBp65/NF-κBp65, p-IκBa/IκBa, TLR2, and TLR4 in rat lung tissue.

NF-kB p65 Antibody - Figure 4 mRNA and protein expression in knee joint and spleen of CIA rats.

NF-kB p65 Antibody - Figure 4 The BGF effects on levels of oxidative stress-related factors and inflammasome factors.

NF-kB p65 Antibody - Figure 4: Changes of IL-1β, IL-6, NF-kB and YY1- mRNA expression in Frontal cortex (A-D), Striatum (E-H), hippocampus (I-L) among CTR (n = 8), CUMS (n = 8) and VOR group (n = 8); (M) Representative western blot image of NF-kB in nuclear level and cytosolic in the hippocampus among CTR, CUMS and VOR groups;.

NF-kB p65 Antibody - Figure 4 The effects of SD treatment on the levels of the TLR4/TRAF6/NF-κB and IL-6/ROR-γt/STAT3 pathways' related genes and proteins in the nasal mucosa of AR mice ((n) = 6).

NF-kB p65 Antibody - Figure 6.

$Fig. 4. Effects of stigmasterol treatment on inflammatory pathways in Aβ42 oligomers induced BV2 cells. Cells were pretreated with Aβ42 oligomers (1 μM) for 24 h, followed by treatment with stigmasterol (10, 20 μM) for 4 h. (A, B) Representative western blot analysis of AMPK signaling. GAPDH immunoreactivity was used as a loading control. (C-G) Representative western blot analysis of NF-κB signaling. The cytosolic fractions were prepared and analyzed with phosphorylated IκBα, total IκBα, and total NF-κB p65. The nuclear fractions were prepared and analyzed with total NF-κB p65. α-Tubulin immunoreactivity was used as a loading control in the cytosolic fraction, Histone H3 was used as the loading control in the nuclear fraction. (H-K) Representative western blot analysis of NLRP3 signaling, including NLRP3, Caspase-1, and Caspase-1, p20. GAPDH immunoreactivity was used as a loading control. Data were presented as the mean ± SEM from three independent experiments. One-way ANOVA with Tukey’s multiple comparison test revealed a difference between groups.$

NF-kB p65 Antibody - Figure 5 Effect of MALT1 mucosa-associated lymphoid tissue lymphoma translocation protein 1 on nuclear factor-κB signaling in proatherogenic VSMCs.

NF-kB p65 Antibody - FIGURE 6 Cinacalcet suppresses the PKCδ/ERK/P65 signaling pathway.

NF-kB p65 Antibody - FIGURE 6 Effect of MLG on NF-κB/Nrf2/HO-1 signaling pathway in ethanol-induced gastric lesions mice.

NF-kB p65 Antibody - FIGURE 3 STIP1 ameliorates ischaemia/reperfusion-induced inflammation in rat spinal cord.

NF-kB p65 Antibody - FIGURE 4 STIP1 restrains OGD-induced inflammation in microglial cells.

NF-kB p65 Antibody - Figure 7 SHFM1 regulates the NF-κB signaling pathway in ESCC cells.

NF-kB p65 Antibody - Figure 5 Relative expression levels of NF-κB pathway-related proteins were measured via western blot assay.

NF-kB p65 Antibody - Figure 6 Effect of DOFE on TLR4-mediated inflammatory response.

NF-kB p65 Antibody - Figure 8.

NF-kB p65 Antibody - Figure 2 The changes in the expression of key proteins of NF-κB and MAPK signaling pathway after LPS stimulation in RECs at different times.

NF-kB p65 Antibody - Figure 10.

NF-kB p65 Antibody - Figure 6 BMP8B triggers NF-κB signaling to suppress adipogenesis.

NF-kB p65 Antibody - Figure 7 Effects of adding sanguinarine to a high-fat diet on NF-κB gene expression and protein expression of grass carp.

NF-kB p65 Antibody - Figure 4 Effects of AdipoRon on p65 and adenosine monophosphate-activated protein kinase (AMPK) phosphorylation under proinflammatory conditions.

NF-kB p65 Antibody - Figure 8 Western blot analysis of the proteins.

NF-kB p65 Antibody - Fig 3 HEX enhances barrier integrity and limits the NF-κB signaling pathway in MMECs.

NF-kB p65 Antibody - Figure 9.

NF-kB p65 Antibody - Figure 4 High-dose VC attenuated the inflammatory response in CLP-induced sepsis rats at 1d, 3d and 5d.

NF-kB p65 Antibody - Figure 6 Luteolin inhibits the activity of the AGE-RAGE signaling pathway.

NF-kB p65 Antibody - Figure 2.

$Figure 2. ASFV A528R inhibits the NF-κB p65 phosphorylation downstream TLR8 signaling. (A) 293T cells grown in 12-well plate (3 × 105 cells/well) were transfected with A528R plasmid (0.25 µg, 0.5 µg), pTLR8 (0.5 µg) as indicated. Twenty-four hours post transfection, cells were stimulated with R848 (5 µg/mL) for 12 h, the expressions of p-p65, p65, A528R, and pTLR8 were analyzed by Western blotting. (B–D) 293T cells were transfected with A528R (0.25 µg, 0.5 µg) or vector (EV) control (0.5 µg), together with MyD88 (0.5 µg) (B), IKK-β (0.5 µg) (C), p65 (0.5 µg) (D). Twenty-four hours later, the expressions of p-p65, p65, A528R, MyD88, IKK-β, p65 were analyzed by Western blotting. (E) 293T cells grown in 12-well plate (3 × 105 cells/well) were transfected with A528R (0.25 µg, 0.5 µg), pTLR8 (0.5 µg). Twenty-four hours post transfection, cells were stimulated with R848 (5 µg/mL) for 12 h. Cell lysates were fractionated into cytoplasmic and nuclear extracts, and the protein levels of p65 and p-p65 in different fractions were analyzed by Western blotting. The histone-H3 and GAPDH were also shown as the nuclear and cytoplasmic markers, respectively.$

NF-kB p65 Antibody - Figure 7 Pretreatment with CH223191 eliminated the blocking effect of 5-HIAA on NF-κB signaling pathway The expression levels of representative proteins of the NF-κB pathway in mammary (A) and colonic (D) tissues were determined in three groups of mice.

NF-kB p65 Antibody - FIGURE 5.